Novavax Inc. announced on Thursday that it filed an application with the World Health Organization for the approval of its COVID-19 vaccine, a month later than original plans suggested.
The American company asked for vaccine approval from the WHO joint by India’s Serum Institute, with the goal of exporting the jab to middle and low-income countries.
The two entities previously pledged to provide the COVAX facility with over 1.1 billion vaccine doses. According to the results of clinical trials in the United States, the shot is 90% effective in preventing COVID-19.
United States National Security Council (NSC) Coordinator for Strategic Communications John Kirby told Al-Jazeera on…
Tunis Court of Appeal confirms the verdict pronounced in the first instance against Ennahdha leader…
Spanish Prime Minister Pedro Sánchez stated on Friday that he would “reveal on Wednesday the…
A patrol affiliated with intelligence units in the National Guard district of Manouba was able…
A middle school in the locality of El Jadida, in the Manouba region, registered the poisoning…
Tabarka National Guard research and investigation brigade carried out a raid on a coral trafficker.…
This website uses cookies.